Hence, we speculate that Q10H2 supplementation may be counterproductive for treating MADD, as Q deficiency in MADD is a cellular compensatory response to ETFDH-mediated reductive stress. Here, ETFDH is linked to multiple acyl-CoA dehydrogenase deficiency.